Systems Biology of Gut Microbiota-Human Receptor Interactions: Toward Anti-inflammatory Probiotics

Area of Science:

• Microbiology
• Immunology
• Systems Biology

Background:

• Global incidence of inflammatory disorders is increasing, with gut microbiome therapeutics showing promise but lacking mechanistic understanding.
• Current probiotic approaches are experimental, context-dependent, and pose risks due to unknown mechanisms, hindering precision medicine.
• Gut microbiota metabolites interact with human receptors like aryl hydrocarbon receptor (AhR), which has anti-inflammatory roles but exhibits tissue-specific signaling.

Purpose of the Study:

• To investigate the tissue-specific signaling of aryl hydrocarbon receptor (AhR) ligands produced by gut bacteria.
• To elucidate the mechanistic basis of host responses to different AhR ligands.
• To leverage systems biology and computational tools for comprehensive strain characterization and precision probiotic development.

Main Methods:

• Utilizing systems biology approaches, including metabolic modeling and machine learning.
• Analyzing the interaction between gut microbial molecules (ligands) and human receptors (e.g., AhR).
• Delineating tissue- and ligand-specific signaling pathways.

Main Results:

• Identified that different AhR ligands induce varying host responses in a tissue-specific manner.
• Highlighted the potential of computational tools to characterize microbial strains and their signaling.
• Demonstrated the complexity of host-microbe interactions in the context of inflammation.

Conclusions:

• Understanding the mechanistic basis of ligand-receptor interactions is crucial for precision probiotics.
• Systems biology and machine learning can bridge the knowledge gap in strain heterogeneity and host responses.
• Further research into AhR ligand signaling is essential for developing targeted anti-inflammatory therapies.